Creo Medical Group PLC (LON:CREO – Get Free Report) shot up 1.2% during mid-day trading on Monday . The stock traded as high as GBX 29.10 ($0.38) and last traded at GBX 29.10 ($0.38). 85,367 shares were traded during trading, a decline of 85% from the average session volume of 588,259 shares. The stock had previously closed at GBX 28.75 ($0.38).
Creo Medical Group Trading Up 1.2 %
The stock has a market cap of £105.28 million, a P/E ratio of -415.71 and a beta of 0.86. The company has a debt-to-equity ratio of 13.88, a quick ratio of 2.19 and a current ratio of 3.83. The stock’s fifty day moving average is GBX 30.05 and its 200 day moving average is GBX 33.37.
About Creo Medical Group
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
See Also
- Five stocks we like better than Creo Medical Group
- The Significance of Brokerage Rankings in Stock Selection
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- What Are Trending Stocks? Trending Stocks Explained
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
